Sites of metastasis and survival in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).
Shaan Dudani(William Osler Health System), Daniel Yick Chin Heng(University of Calgary), Camillo Porta(University of Pavia), Aaron R. Hansen(Princess Margaret Cancer Centre), Aly‐Khan A. Lalani(Juravinski Cancer Centre), Benoit Beuselinck(Universitair Ziekenhuis Leuven), Connor Wells(Queen Mary University of London), Ravindran Kanesvaran(University of Ioannina), Felice Pasini(Ospedale Civile Di Ivrea), Sumanta K. Pal(City of Hope), Chun Loo Gan(University of Calgary), Frede Donskov(Aarhus University Hospital), Sebastién J. Hotte(Juravinski Cancer Centre), Georg A. Bjarnason(Sunnybrook Health Science Centre), Anna Paola Fraccon, Takeshi Yuasa(Japanese Foundation For Cancer Research), Guillermo de Velasco(Dana-Farber Cancer Institute), Christina M. Canil(University of Ottawa), Toni K. Choueiri(Harvard University), M. Neil Reaume(The University of Melbourne)
Cited by 31
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.3k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k